Neelakshi Gohain

Title: Neelakshi Gohain: Innovator in HIV Immunogen Research

Introduction

Neelakshi Gohain is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines against HIV. His innovative work focuses on creating stable immunogens that can effectively induce immunity against the Human Immunodeficiency Virus (HIV).

Latest Patents

Neelakshi Gohain holds a patent for a "Stable immunogen based on inner domain of HIV-1 gp120 for inducing immunity against HIV." This patent describes stable immunogens that comprise portions of the inner domain (ID) of the HIV-1 gp120 protein. These ID immunogens selectively present the gp120 C1/C2 region in its CD4-bound state within a minimal structure. The immunogens can be utilized to vaccinate subjects against HIV, the causative agent of Acquired Immunodeficiency Syndrome (AIDS). Additionally, these immunogens can serve as targets in screening to identify small molecule or peptide inhibitors that block HIV-1 viral entry and attachment steps. They can also be used as probes for identifying gp120 C1/C2 region-specific antibodies. Neelakshi Gohain has 1 patent to his name.

Career Highlights

Neelakshi Gohain is affiliated with the University System of Maryland, where he conducts his research. His work has been instrumental in advancing the understanding of HIV and developing potential therapeutic strategies.

Collaborations

Neelakshi has collaborated with notable colleagues, including Marzena Pazgier and George K Lewis. These collaborations have further enriched his research and contributed to the scientific community's efforts in combating HIV.

Conclusion

Neelakshi Gohain's innovative research in the field of HIV immunology highlights his commitment to advancing medical science. His contributions through patents and collaborations are paving the way for potential breakthroughs in HIV prevention and treatment.